Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongxinluo for carotid artery plaque intervention
ChiCTR-TRC-08000212Phase 4Completed
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tongxinluo in carotid atheroma (CAS) and atherosclerosis (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoint: Between-group difference in change in mean carotid intima-media thickness. Started Dec 2008; status: completed.
02
Drugs
Tongxinluo
03
Conditions
carotid atheroma (CAS)atherosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-08000212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000212.